Biostar Pharmaceutical Provides Unaudited Preliminary Updates (BSPM)

Comments
Loading...
Biostar Pharmaceutical BSPM announces unaudited October and November 2010 combined revenues increased 68% to approximately $18.3 million; Sales of Xin Aoxing increased 67% to $12.4 million. Biostar Pharmaceutical's rural distribution network surpasses 9,500 locations; on track to reach 10,000 by December 31, 2010.
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: